BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $180,816,000 | -26.1% | 1,240,932 | -40.4% | 54.93% | +13.6% |
| Q1 2022 | $244,632,000 | -14.5% | 2,081,402 | +0.3% | 48.37% | +19.0% |
| Q4 2021 | $286,011,000 | -3.8% | 2,075,402 | -5.8% | 40.64% | +9.8% |
| Q3 2021 | $297,221,000 | +45.7% | 2,204,055 | -5.4% | 37.00% | +31.6% |
| Q2 2021 | $203,994,000 | +40.5% | 2,330,755 | +8.1% | 28.12% | +29.3% |
| Q1 2021 | $145,143,000 | -21.3% | 2,156,871 | -4.1% | 21.74% | -6.0% |
| Q4 2020 | $184,528,000 | +36.4% | 2,248,271 | +4.9% | 23.12% | +29.7% |
| Q3 2020 | $135,306,000 | -9.5% | 2,142,900 | +3.3% | 17.83% | -6.0% |
| Q2 2020 | $149,569,000 | +134.1% | 2,074,800 | +5.3% | 18.98% | -0.0% |
| Q1 2020 | $63,879,000 | -39.0% | 1,970,743 | +2.5% | 18.98% | -3.4% |
| Q4 2019 | $104,704,000 | +35.9% | 1,923,290 | -23.1% | 19.66% | +3.7% |
| Q3 2019 | $77,029,000 | +4.2% | 2,502,275 | +17.4% | 18.95% | +19.1% |
| Q2 2019 | $73,950,000 | +32.1% | 2,131,750 | +21.1% | 15.91% | +33.5% |
| Q1 2019 | $55,986,000 | +767.5% | 1,760,392 | +908.6% | 11.91% | +495.1% |
| Q4 2018 | $6,454,000 | – | 174,535 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |